ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,514.39
      -1.52%
      US Tech 100
      18,724.00
      -1.85%
      Dow Jones
      40,773.04
      -1.40%
      Brent Oil
      69.62
      -1.51%
      Bitcoin
      80,166.02
      -4.19%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Hemostemix Inc (QB) (HMTXF) Quote

      Hemostemix Inc (QB)

      Hemostemix Inc (QB) (HMTXF)

      USOTC
      0.0862
      0.001
      ( 1.17% )
      Updated: 13:11:43
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.0862
      Bid
      0.08
      Ask
      0.089
      Volume
      13,617
      0.0862 Day's Range 0.0865
      0.024 52 Week Range 0.285
      Market Cap
      12.21M
      Previous Close
      0.0852
      Open
      0.0865
      Last Trade
      5617
      @
      0.0862
      Last Trade Time
      13:03:23
      Financial Volume
      $ 1,176
      VWAP
      0.086376
      Average Volume (3m)
      60,348
      Shares Outstanding
      141,641,969
      Dividend Yield
      -
      PE Ratio
      -6.21
      Earnings Per Share (EPS)
      -0.02
      Revenue
      200k
      Net Profit
      -2.5M

      About Hemostemix Inc (QB)

      Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Blank Checks
      Website
      www.hemostemix.com
      Headquarters
      Calgary, Alberta, Can
      Founded
      2014
      Hemostemix Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker HMTXF. The last closing price for Hemostemix (QB) was $0.09. Over the last year, Hemostemix (QB) shares have traded in a share price range of $ 0.024 to $ 0.285.

      Hemostemix (QB) currently has 141,641,969 shares outstanding. The market capitalization of Hemostemix (QB) is $12.07 million. Hemostemix (QB) has a price to earnings ratio (PE ratio) of -6.21.

      Ask ADVFN Intelligence (AI)

      HMTXF Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.03135-26.66950233940.117550.117550.08411680.0896999CS
      4-0.0826-48.93364928910.16880.16880.08356760.10699929CS
      120.0323560.07428040850.053850.2850.05385603480.18793673CS
      260.036272.40.050.2850.0323463730.15117068CS
      520.034667.05426356590.05160.2850.024343730.13574849CS
      156-0.0708-45.09554140130.1570.32790.024260530.14927561CS
      2600.0664335.3535353540.01980.43720.0051363230.09598444CS

      HMTXF - Frequently Asked Questions (FAQ)

      What is the current Hemostemix (QB) share price?
      The current share price of Hemostemix (QB) is $ 0.0862
      How many Hemostemix (QB) shares are in issue?
      Hemostemix (QB) has 141,641,969 shares in issue
      What is the market cap of Hemostemix (QB)?
      The market capitalisation of Hemostemix (QB) is USD 12.07M
      What is the 1 year trading range for Hemostemix (QB) share price?
      Hemostemix (QB) has traded in the range of $ 0.024 to $ 0.285 during the past year
      What is the PE ratio of Hemostemix (QB)?
      The price to earnings ratio of Hemostemix (QB) is -6.21
      What is the cash to sales ratio of Hemostemix (QB)?
      The cash to sales ratio of Hemostemix (QB) is 78.57
      What is the reporting currency for Hemostemix (QB)?
      Hemostemix (QB) reports financial results in CAD
      What is the latest annual turnover for Hemostemix (QB)?
      The latest annual turnover of Hemostemix (QB) is CAD 200k
      What is the latest annual profit for Hemostemix (QB)?
      The latest annual profit of Hemostemix (QB) is CAD -2.5M
      What is the registered address of Hemostemix (QB)?
      The registered address for Hemostemix (QB) is SUITE 1150, 707-7TH AVE SW, CALGARY, CALGARY, ALBERTA, T2P 3H6
      What is the Hemostemix (QB) website address?
      The website address for Hemostemix (QB) is www.hemostemix.com
      Which industry sector does Hemostemix (QB) operate in?
      Hemostemix (QB) operates in the BLANK CHECKS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc (CE)
      $ 0.008
      (799,900.00%)
      		100
      MRPSMicrophonics Inc (CE)
      $ 0.0001
      (9,900.00%)
      		1,000
      CONNQConns Inc (CE)
      $ 0.0001
      (9,900.00%)
      		1,000
      BOTYLingerie Fighting Championships Inc (PK)
      $ 0.0001
      (9,900.00%)
      		243.5k
      AGILQAgileThought Inc (CE)
      $ 0.0001
      (9,900.00%)
      		23.35k
      LRKKFLark Distilling Company Ltd (PK)
      $ 0.0015
      (-99.81%)
      		1,000
      CLVRClever Leaves Holdings Inc (CE)
      $ 0.000001
      (-99.50%)
      		1.13k
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.000001
      (-99.00%)
      		4.06M
      BLSPBlue Sphere Corporation (CE)
      $ 0.000001
      (-99.00%)
      		264k
      NWPNNow Corp (PK)
      $ 0.000001
      (-99.00%)
      		2.1M
      ASIIAccredited Solutions Inc (PK)
      $ 0.0003
      (-25.00%)
      		210.31M
      GRLTGrillit Inc (PK)
      $ 0.0009
      (0.00%)
      		193.18M
      TPTWTPT Global Tech Inc (PK)
      $ 0.0002
      (0.00%)
      		133.41M
      NNAXNew Momentum Corporation (PK)
      $ 0.0007
      (27.27%)
      		119.12M
      RONNRonn Motor Group Inc (PK)
      $ 0.0002
      (100.00%)
      		106.6M

      HMTXF Discussion

      View Posts
      georgie18 georgie18 1 day ago
      HMTXF...089...🥳...OTC partnering with a NAZ company sounds promising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for various forms of cardiovascular disease, including vascular dementia, announces its collaboration with Firefly Neuroscience, Inc. (NASDAQ: AIFF) ("Firefly"), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders.

      Hemostemix and Firefly will study brain wave activity in up to 100 patients before and after treatment with ACP-01 at baseline, 3-months, and 6-months post-treatment (the "Phase 1").

      https://www.otcmarkets.com/stock/HMTXF/news/Hemostemix-and-FireFly-Neurosciences-Brain-Network-Analytics-BNATM-Engage-to-Complete-Phase-1-Vascular-Dementia-Clinical?id=469780
      👍️0
      rodman rodman 3 weeks ago
      Still following Hemostemix? I would be engaged for the short run up!
      $1+
      👍️0
      rodman rodman 3 weeks ago
      Looking like Hemostemix may be an emerging leader in the stem cell arena? Now the recent pr announced the lowest COGS cost of goods in the industry?
      $1.+
      👍️0
      JamesMacho JamesMacho 1 year ago
      Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.
      👍️0
      tw0122 tw0122 2 years ago
      Boom boom time
      👍️0

      Your Recent History

      USOTC
      HMTXF
      Hemostemix (QB)
      BIT
      UC92UD
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads